Let's Talk MRSA: 20 Frequently Asked Questions

Por: Vemco MedEd

Designed to clarify persistent issues in serious MRSA infections that pose
a threat to patient safety and add to the healthcare burden. Experts answer frequently asked questions and share their own clinical experience. This activity consists of 20 episodes that will be released weekly beginning October 4, 2010.
20 episodios disponibles

Latest episodes of the podcast Let's Talk MRSA: 20 Frequently Asked Questions

What are the short- and long-term challenges as well as advancements that will impact the management of patients with MRSA infections? 13/02/2011
How can we prevent the spread of MRSA in the hospital? 06/02/2011
Is there a role for OPAT in the management of patients with MRSA infections? 30/01/2011
Can we determine the appropriate duration of therapy for MRSA infections? 23/01/2011
What stewardship tactics can be applied to the management of MRSA infections? 16/01/2011
Can we differentiate among newer agents for MRSA bacteremia and endocarditis? 09/01/2011
How should clinicians manage MRSA bacteremia and infective endocarditis? 02/01/2011
How can primary care physicians manage community-associated MRSA pneumonia? 26/12/2010
What is the optimal treatment for MRSA nosocomial pneumonia? 19/12/2010
What are the therapeutic options for a complicated skin or skin structure MRSA infection? 12/12/2010
How can clinicians optimally manage community-associated MRSA skin infections? 05/12/2010
What strategies can be used to effectively manage patients with skin and soft tissue MRSA infections? 28/11/2010
When should an alternative agent to vancomycin be considered for MRSA infections? 21/11/2010
What are the toxicity concerns associated with using vancomycin for MRSA infections? 14/11/2010
Should therapeutic drug monitoring be considered when using vancomycin for MRSA infections? 07/11/2010
What is the appropriate vancomycin dosing to maximize its effectiveness? 31/10/2010
What is vancomycin 'MIC creep'? 24/10/2010
What is community-associated MRSA? How is it different from healthcare-acquired MRSA? 17/10/2010
Why is the prevalence of MRSA increasing in the hospital setting? 10/10/2010
Why is MRSA such a problematic pathogen? 29/09/2010
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA